Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients
Psychoeducation for Spouses/Partners of Women With Breast Cancer
Status: Enrolling
Updated:  2/6/2018
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients
Psychoeducation for Spouses/Partners of Women With Breast Cancer
Status: Enrolling
Updated: 2/6/2018
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Vilazodone for Separation Anxiety Disorder
Vilazodone for Separation Anxiety Disorder
Status: Enrolling
Updated:  2/6/2018
New York State Psychiatric Institute
mi
from
New York, NY
Vilazodone for Separation Anxiety Disorder
Vilazodone for Separation Anxiety Disorder
Status: Enrolling
Updated: 2/6/2018
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Topiramate Treatment of Problem Drinkers
Topiramate Treatment of Problem Drinkers
Status: Enrolling
Updated:  2/7/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Topiramate Treatment of Problem Drinkers
Topiramate Treatment of Problem Drinkers
Status: Enrolling
Updated: 2/7/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Sustained Effects of Ketamine
The Sustained Effects of Ketamine
Status: Enrolling
Updated:  2/7/2018
Yale Center for Clinical Investigation, Yale University
mi
from
New Haven, CT
The Sustained Effects of Ketamine
The Sustained Effects of Ketamine
Status: Enrolling
Updated: 2/7/2018
Yale Center for Clinical Investigation, Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
Status: Enrolling
Updated:  2/12/2018
Connecticut Mental Health Center & Yale-New Haven Hospital
mi
from
New Haven, CT
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
Status: Enrolling
Updated: 2/12/2018
Connecticut Mental Health Center & Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Birmingham, AL
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Baltimore, MD
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Bronx, NY
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Cleveland, OH
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Milwaukee, WI
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pharmacoepigenetics of Bipolar Disorder Treatment
Pharmacoepigenetics of Second Generation Antipsychotic-Induced Insulin Resistance in Bipolar Disorder
Status: Enrolling
Updated:  2/12/2018
Wayne State University Clinical Research Center
mi
from
Detroit, MI
Pharmacoepigenetics of Bipolar Disorder Treatment
Pharmacoepigenetics of Second Generation Antipsychotic-Induced Insulin Resistance in Bipolar Disorder
Status: Enrolling
Updated: 2/12/2018
Wayne State University Clinical Research Center
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Oceanside, CA
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
San Diego, CA
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Deerfield Beach, FL
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
North Miami, FL
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Naperville, IL
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Naperville, IL
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Indianapolis, IN
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Lafayette, IN
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Lafayette, IN
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Shreveport, LA
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Boston, MA
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Albuquerque, NM
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Canton, OH
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Portland, OR
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
mi
from
Havertown, PA
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
mi
from
Havertown, PA
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Nashville, TN
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Austin, TX
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Desoto, TX
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Desoto, TX
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Houston, TX
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Charlottesville, VA
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Kirkland, WA
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated:  2/12/2018
Clinical Research Facility
mi
from
Seattle, WA
A Study in the Treatment of Alcohol Dependence.
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
Status: Enrolling
Updated: 2/12/2018
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Behavioral Therapy Development for Methamphetamine Abusers
Behavioral Therapy Development for Methamphetamine Abuse
Status: Enrolling
Updated:  2/13/2018
UCLA CARE Clinic
mi
from
Los Angeles, CA
Behavioral Therapy Development for Methamphetamine Abusers
Behavioral Therapy Development for Methamphetamine Abuse
Status: Enrolling
Updated: 2/13/2018
UCLA CARE Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Behavioral Therapy Development for Methamphetamine Abusers
Behavioral Therapy Development for Methamphetamine Abuse
Status: Enrolling
Updated:  2/13/2018
UCLA Medical Center
mi
from
Los Angeles, CA
Behavioral Therapy Development for Methamphetamine Abusers
Behavioral Therapy Development for Methamphetamine Abuse
Status: Enrolling
Updated: 2/13/2018
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Behavioral Therapy Development for Methamphetamine Abusers
Behavioral Therapy Development for Methamphetamine Abuse
Status: Enrolling
Updated:  2/13/2018
UCLA, Integrated Substance Abuse Programs
mi
from
Los Angeles, CA
Behavioral Therapy Development for Methamphetamine Abusers
Behavioral Therapy Development for Methamphetamine Abuse
Status: Enrolling
Updated: 2/13/2018
UCLA, Integrated Substance Abuse Programs
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Combined Treatment for Alcohol-Dependent Individuals With PTSD
Combined Treatment for Alcohol-Dependent Individuals With PTSD
Status: Enrolling
Updated:  2/13/2018
City College, City University of New York
mi
from
New York, NY
Combined Treatment for Alcohol-Dependent Individuals With PTSD
Combined Treatment for Alcohol-Dependent Individuals With PTSD
Status: Enrolling
Updated: 2/13/2018
City College, City University of New York
mi
from
New York, NY
Click here to add this to my saved trials
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder
Status: Enrolling
Updated:  2/13/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder
Status: Enrolling
Updated: 2/13/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence
The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence
Status: Enrolling
Updated:  2/13/2018
Johns Hopkins Bayview Center for Learning and Health
mi
from
Baltimore, MD
The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence
The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence
Status: Enrolling
Updated: 2/13/2018
Johns Hopkins Bayview Center for Learning and Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Extended Release Naltrexone for Opioid-Dependent Youth
Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth
Status: Enrolling
Updated:  2/13/2018
Friends Research Institute
mi
from
Baltimore, MD
Extended Release Naltrexone for Opioid-Dependent Youth
Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth
Status: Enrolling
Updated: 2/13/2018
Friends Research Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Extended Release Naltrexone for Opioid-Dependent Youth
Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth
Status: Enrolling
Updated:  2/13/2018
Mountain Manor Treatment Center
mi
from
Baltimore, MD
Extended Release Naltrexone for Opioid-Dependent Youth
Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth
Status: Enrolling
Updated: 2/13/2018
Mountain Manor Treatment Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
LearningRx Cognitive Training for ADHD
LearningRx Cognitive Training for ADHD: A Multiple Baseline Study Across Cases
Status: Enrolling
Updated:  2/13/2018
Gibson Institute of Cognitive Research
mi
from
Colorado Springs, CO
LearningRx Cognitive Training for ADHD
LearningRx Cognitive Training for ADHD: A Multiple Baseline Study Across Cases
Status: Enrolling
Updated: 2/13/2018
Gibson Institute of Cognitive Research
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
A Pilot Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Status: Enrolling
Updated:  2/13/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
A Pilot Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Status: Enrolling
Updated: 2/13/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
A Human Laboratory Assessment of the Safety and Potential Efficacy of Varenicline in Methamphetamine-dependent Volunteers Receiving Methamphetamine
Status: Enrolling
Updated:  2/13/2018
UCLA NPI
mi
from
Los Angeles, CA
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
A Human Laboratory Assessment of the Safety and Potential Efficacy of Varenicline in Methamphetamine-dependent Volunteers Receiving Methamphetamine
Status: Enrolling
Updated: 2/13/2018
UCLA NPI
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Tranylcypromine Treatment of Bipolar Depression
Tranylcypromine Treatment of Bipolar Depression
Status: Enrolling
Updated:  2/15/2018
New York State Psychiatric Institute
mi
from
New York, NY
Tranylcypromine Treatment of Bipolar Depression
Tranylcypromine Treatment of Bipolar Depression
Status: Enrolling
Updated: 2/15/2018
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Computer Based Training in Cognitive Behavioral Therapy Web-based
Computer Based Training in Cognitive Behavioral Therapy Web-based
Status: Enrolling
Updated:  2/15/2018
Substance Abuse Treatment Unit (SATU)
mi
from
New Haven, CT
Computer Based Training in Cognitive Behavioral Therapy Web-based
Computer Based Training in Cognitive Behavioral Therapy Web-based
Status: Enrolling
Updated: 2/15/2018
Substance Abuse Treatment Unit (SATU)
mi
from
New Haven, CT
Click here to add this to my saved trials
Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
Effectiveness of Omega-3 Fatty Acids for the Reduction of Hyperactivity in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  2/16/2018
This study is open to continental USA
mi
from
Multiple Locations, MD
Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
Effectiveness of Omega-3 Fatty Acids for the Reduction of Hyperactivity in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 2/16/2018
This study is open to continental USA
mi
from
Multiple Locations, MD
Click here to add this to my saved trials
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  2/16/2018
Haleyville Clinical Research LLC
mi
from
Haleyville, AL
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 2/16/2018
Haleyville Clinical Research LLC
mi
from
Haleyville, AL
Click here to add this to my saved trials
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  2/16/2018
Boyett Health Services
mi
from
Hamilton, AL
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 2/16/2018
Boyett Health Services
mi
from
Hamilton, AL
Click here to add this to my saved trials
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  2/16/2018
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 2/16/2018
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials